| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/07/2009 | WO2008054200A3 Use of nutritional compositions for preventing disorders |
| 05/07/2009 | WO2006123355A3 Novel statin derivatives |
| 05/07/2009 | US20090118699 Systems and methods for treating obesity and other gastrointestinal conditions |
| 05/07/2009 | US20090118518 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them |
| 05/07/2009 | US20090118361 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor |
| 05/07/2009 | US20090118360 Process for manufacturing leaf tea |
| 05/07/2009 | US20090118345 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | US20090118332 Therapeutic Agents - 551 |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118306 Novel use of liver X receptor agonists |
| 05/07/2009 | US20090118304 2-heteroaryl-substituted indole derivative |
| 05/07/2009 | US20090118300 Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118296 Heteroaromatic Compounds As Inhibitors Of Stearoyl-Coenzyme A Delta-9 Desaturase |
| 05/07/2009 | US20090118287 Organic compounds |
| 05/07/2009 | US20090118283 Amide Derivatives as Kinase Inhibitors |
| 05/07/2009 | US20090118278 Compositions useful as inhibitors of gsk-3 |
| 05/07/2009 | US20090118265 Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use |
| 05/07/2009 | US20090118259 Pharmaceutical use of substituted amides |
| 05/07/2009 | US20090118254 Histamine h3 receptor agents, preparation and therapeutic uses |
| 05/07/2009 | US20090118252 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118251 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118250 Pharmaceutical composition |
| 05/07/2009 | US20090118236 such as 2-[(3,5-dimethyl-4-(4'-hydroxy-3'-iso-propylbenzyl) phenoxy)methyl]-4-(3-chlorophenyl)-2-oxo-2 lambda 5-[1,3,2]-dioxaphosphonane, used for preventing and/or treating metabolic disorders such as obesity, hypercholesterolemia and hyperlipidemia |
| 05/07/2009 | US20090118229 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118228 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118227 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118201 Benzylbenzene derivatives and methods of use |
| 05/07/2009 | US20090118194 Measurement of melanocortin peptides and uses thereof |
| 05/07/2009 | US20090118192 sequentially administering parathyroid hormone and bone resorption inhibitor; bone disorders; osteoporosis |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090118159 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt thereof; chemical synthesis to obtain antidiabetic agent |
| 05/07/2009 | US20090118158 peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), pH control agent (arginine, sodium hydroxide, glycine, hydrochloric acid) and preservatives ( methylparaben or propylparaben); eating disorder |
| 05/07/2009 | US20090117214 Extract Of Fraxinus Excelsior Seeds And Therapeutic Applications Therefor |
| 05/07/2009 | US20090117208 Amino acid composition and supplementary liquid containing the same |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117102 Methods and compositions using CD3 agonists |
| 05/07/2009 | US20090117064 Stable vitamin b6 derivative |
| 05/07/2009 | DE4042752B4 Verfahren zur Herstellung von Mikropartikeln, welche einen Wirkstoff in einem bioabbaubaren polymeren Träger enthalten Process for the preparation of microparticles containing an active agent in a biodegradable polymeric carrier, |
| 05/07/2009 | CA2707861A1 Glucagon antagonists |
| 05/07/2009 | CA2704780A1 Method of treating vitamin b12 deficiency |
| 05/07/2009 | CA2704529A1 Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor |
| 05/07/2009 | CA2704336A1 Amide derivatives as sirtuin modulators |
| 05/07/2009 | CA2703693A1 Anti-fatigue agent comprising amino acid composition |
| 05/07/2009 | CA2703683A1 Novel nacl salt substitute, use thereof and products containing same |
| 05/07/2009 | CA2703217A1 Antidiabetic tricyclic compounds |
| 05/07/2009 | CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | CA2702289A1 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 05/07/2009 | CA2696237A1 Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055703A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 05/06/2009 | EP2055302A1 Method for the improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/06/2009 | EP2055301A1 Solid oral dosage forms comprising valsartan |
| 05/06/2009 | EP2054437A2 Albumin-insulin fusion proteins |
| 05/06/2009 | EP2054434A1 Myostatin antagonists |
| 05/06/2009 | EP2054408A2 Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid level |
| 05/06/2009 | EP2054386A2 Non-flushing niacin analogues, and methods of use thereof |
| 05/06/2009 | EP2054385A2 Phenyl, pyridine and quinoline derivatives |
| 05/06/2009 | EP2054381A2 Pharmacodynamic hybrids endowed of hypoglycemic and no-donor activities obtained combining hydroxylated derivatives of glibenclamide and nitrooxy-substituted carboxylic acids |
| 05/06/2009 | EP2054374A1 Novel hydrate form of o-desmethyl venlafaxine succinate |
| 05/06/2009 | EP2054070A2 A novel herbal drug and a process for preparation thereof for the prevention and management of endothellal dysfunction among type-ii diabetes mellitus cases |
| 05/06/2009 | EP2054058A2 Inhibitors of pyruvate kinase and methods of treating disease |
| 05/06/2009 | EP1945635B1 Thiazolyl piperidine derivatives useful as h3 receptor modulators |
| 05/06/2009 | EP1778655B1 2 - { - 3 2 - (phenyl)-oxazol-4-ylmethoxyl-cyclohexylmethoxy}-propionic acid derivatives used as ppar ligands (peroxisome proliferator-activated receptors) for the treatment of hyperlipidaemie and diabetes |
| 05/06/2009 | EP1729774A4 Pyrrolidine compounds |
| 05/06/2009 | EP1599453B1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 05/06/2009 | EP1474174B1 Composition for oral or rectal administration |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1436264B9 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/06/2009 | EP1385506B1 Acylated piperidine derivates as melanocortin-4 receptor agonists |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | CN201230969Y Coated creatine |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426783A Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426780A Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426775A Oxadiazolidinedione compound |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426513A Composition containing peptide as active ingredient |
| 05/06/2009 | CN101426496A Treatment of nonalcoholic fatty liver disease using cholesterol lowering agents and H3 receptor antagonist/inverse agonist |
| 05/06/2009 | CN101426495A CB1 antagonists and inverse agonists |
| 05/06/2009 | CN101426492A Inhibitor of increase in postprandial blood insulin level |
| 05/06/2009 | CN101426478A Fluvastatin sodium pharmaceutical compositions |
| 05/06/2009 | CN101423551A Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded; and uses thereof |
| 05/06/2009 | CN101423511A Ezetimible intermediate and synthetic method of ezetimible |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101423493A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101423492A Aripiprazole anhydride crystal, method for producing the same and medicinal preparation containing the same |
| 05/06/2009 | CN101423484A Method for preparing probucol raw medicine |
| 05/06/2009 | CN101422568A Shen flavor capsule capable of reducing blood sugar and preparation method thereof |
| 05/06/2009 | CN101422567A Traditional Chinese medicine cosmetic body-building liquor |
| 05/06/2009 | CN101422551A Traditional Chinese medicine body scenting and building liquid |
| 05/06/2009 | CN101422544A Haifei capsule formulation with weight reduction function and preparation method thereof |
| 05/06/2009 | CN101422519A Lipid-lowering traditional Chinese medicine preparation |
| 05/06/2009 | CN101422492A Use of nano gingko liquid |
| 05/06/2009 | CN101422491A Preparation method of inonotus obilquus as alpha-glucosidase inhibitors |